• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Potential role for angiotensin-converting enzyme inhibitors in the treatment of patients with normal-tension glaucoma

Research Project

Project/Area Number 20592078
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Ophthalmology
Research InstitutionKagawa University

Principal Investigator

HIROOKA Kazuyuki  Kagawa University, 医学部附属病院, 講師 (10325350)

Co-Investigator(Kenkyū-buntansha) SHIRAGA Fumio  香川大学, 医学部, 教授 (50187530)
BABA Tetsuya  香川大学, 医学部, 准教授 (20252968)
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2008: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords緑内障 / 神経保護 / アンジオテンシンIIタイプ1 / 受容体拮抗薬 / アンジオテンシン変換酵素阻害薬 / グルタミン酸濃度 / 血流量 / アンジオテンシンIIタイプI受容体拮抗薬 / カンデサルタン / 網膜神経保護 / アンジオテンシンIIタイプI受容体(5) / レニン・アンジオテンシン系 / 虚血・再潅流モデル / アンジオテンシンIIタイプ2受容体拮抗薬
Research Abstract

We investigate the neuroprotective effect of candesartan, an angiotensin II type 1 receptor blocker, against the neurotoxicity of the retinal ganglion cells (RGCs) in an animal model of glaucoma. Cauterization of 3 episcleral vessels in rats was used to create chronically and elevated intraocular pressure (IOP) in one eye. Rats were then orally treated with candesartan (1mg/kg/day). As compared to the contralateral control eyes, there was a consistently elevated IOP of approximately 2.5-fold during the experimental period. As compared to the contralateral control eyes that had normal IOPs, the RGC survival rate in the central retina of eyes with the chronic, elevated IOP was 46.5% in the untreated animals and 84.2% in the candesartan-treated animals. In the rat chronic glaucoma model, continuous pharmacological treatment using candesartan results in significant neuroprotection against RGC loss.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (8 results)

All 2010 2009 2008

All Journal Article (4 results) (of which Peer Reviewed: 2 results) Presentation (4 results)

  • [Journal Article] Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.2010

    • Author(s)
      Kouki Fukuda, Kazuyuki Hirooka, Masanori Mizote, Takehiro Nakamura, Toshifumi Itano, Fumio Shiraga.
    • Journal Title

      Invest Ophthalmol Vis Sci 51

      Pages: 3629-3638

    • Related Report
      2010 Final Research Report
  • [Journal Article] Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type I receptor2010

    • Author(s)
      Fukuda Kouki
    • Journal Title

      Investigative Ophthalmology & Visual Science

      Volume: 51 Pages: 3629-3638

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.2009

    • Author(s)
      Hongwei Yang, Kazuyuki Hirooka, Kouki Fukuda, Fumio Shiraga.
    • Journal Title

      Invest Ophthalmol Vis Sci 50

      Pages: 5800-5804

    • Related Report
      2010 Final Research Report
  • [Journal Article] Neuroprotective effects of angiotensin II type I receptor blocker in a rat model of chronic glaucoma2009

    • Author(s)
      Yang H, Hirooka K, et al.
    • Journal Title

      Investigative Ophthalmology & Visual Science 50

      Pages: 5800-5804

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Presentation] ラット緑内障モデルにおけるアンジオテンシンIIタイプI受容体拮抗薬の神経保護効果2009

    • Author(s)
      廣岡一行, 他
    • Organizer
      第20回日本緑内障学会
    • Place of Presentation
      沖縄
    • Year and Date
      2009-11-14
    • Related Report
      2009 Annual Research Report
  • [Presentation] ラット緑内障モデルにおけるアンジオテンシンIIタイプ1受容体拮抗薬の神経保護効果2009

    • Author(s)
      廣岡一行、楊宏偉、福田恒輝、白神史雄
    • Organizer
      第20回日本緑内障学会
    • Place of Presentation
      沖縄
    • Related Report
      2010 Final Research Report
  • [Presentation] Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of glaucoma.2009

    • Author(s)
      廣岡一行, 楊宏偉, 福田恒輝, 白神史雄
    • Organizer
      World Glaucoma Congress 2009
    • Place of Presentation
      Boston, USA
    • Related Report
      2010 Final Research Report
  • [Presentation] レニン・アンジオテンシン系阻害薬による網膜虚血再潅流モデルにおける神経保護効果2008

    • Author(s)
      福田恒輝、廣岡一行、溝手雅宣、白神史雄
    • Organizer
      第113回日本眼科学会総会
    • Place of Presentation
      東京
    • Related Report
      2010 Final Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi